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INVITED COMMENTARYCommentary on ‘Ultrasound-guided Intralesional Diode Laser Treatment of
Congenital Extratruncular Venous Malformations: Mid-term Results’
B.B. Lee
Center for the Lymphedema and Vascular Malformations, George Washington University, Washington, DC, USAJiang et al. reported successful results of endoluminal laser
therapy (ELT) on extratruncular venous malformation (VM)
lesions using ultrasound-guided intralesional diode laser
method.1 A new role for ELT in extratruncular VM man-
agement has yet to be established, although ELT has been
well accepted for varicose vein management. The VM lesion
is not a fully matured normal vein, it is a residual embryonic
tissue remnant following the defective development, so its
clinical behavior/response to ELT and long-term outcome
will be quite different from those of varicose veins.2
Extratruncular type VM lesion is the outcome of devel-
opmental arrest occurring at a reticular stage of embryonic
life before the venous trunk is formed (cf. truncular lesion).
Therefore, like all other extratruncular congenital vascular
malformations (CVMs), this primitive venous tissue retains
the characteristics of mesenchymal cells (angioblasts) to
grow when stimulated (e.g. trauma, surgery, female hor-
mone, menarche, pregnancy).3
Therefore, extratruncular VM lesions have a perpetual
risk of recurrence after suboptimum management;
improper treatment strategy often stimulates dormant le-
sions to respond in an erratic way. Such inﬁltrating lesions
have a notorious reputation for high tendency to progress
and high recurrence even with a well-established treatment
plan (surgery; embolo-sclerotherapy).2,3
Laser therapy on extratruncular VM is no exception; it is
not better than any other forms of treatment modality (e.g.
foam sclerotherapy), but rather more vulnerable as its
experience is mostly with Nd:YAG as an interstitial form to
superﬁcially located localized VM lesions. Besides, all the
principles of laser application to the VM were adopted fromDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.02.014
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Although they are similar, the goal of treatment for the VM
lesions is to destroy the pathologic vascular structure
completely to avoid recurrence, whereas the aim for the
hemangiomas is to induce regression or ﬁbrosis before
spontaneous regression.4 This means that its parameters to
treat the VM must be more aggressive because of the
unique nature of the lesion, including the wavelength, en-
ergy level, and pulse duration of the laser exposure.
Appropriate consideration of this risk should be included to
establish a new role of ELT for extratruncular VM with
inherent risk of recurrence as an embryonic tissue remnant.
After all, endovenous laser ablations of saphenous vein and
extratruncular VMs are as different as apples and oranges.REFERENCES
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